Related references
Note: Only part of the references are listed.The secretory leukocyte protease inhibitor (SLPI) suppresses cancer cell invasion but promotes blood-borne metastasis via an invasion-independent pathway
T. Sugino et al.
JOURNAL OF PATHOLOGY (2007)
The role of secretory leucoprotease inhibitor in the resolution of inflammatory responses
S. Weldon et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Comparative sequence analyses reveal rapid and divergent evolutionary changes of the WFDC locus in the primate lineage
Belen Hurle et al.
GENOME RESEARCH (2007)
Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI
Weifeng Xu et al.
NATURE IMMUNOLOGY (2007)
The tumor-promoting effect of TNF-α involves the induction of secretory leukocyte protease inhibitor
Nick Devoogdt et al.
JOURNAL OF IMMUNOLOGY (2006)
Human lung project:: Evaluating variance of gene expression in the human lung
Michael P. Gruber et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2006)
The secretory leukocyte protease inhibitor is a type 1 insulin-like growth factor receptor-regulated protein that protects against liver metastasis by attenuating the host proinflammatory response
N Wang et al.
CANCER RESEARCH (2006)
Proteins with whey-aicidic-protein motifs and cancer
D Bouchard et al.
LANCET ONCOLOGY (2006)
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
AH Bild et al.
NATURE (2006)
Secretory leucoprotease inhibitor binds to NF-κB binding sites in monocytes and inhibits p65 binding
CC Taggart et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease
HM Kluger et al.
CANCER RESEARCH (2005)
In silico chromosomal clustering of genes displaying altered expression patterns in ovarian cancer
O Israeli et al.
CANCER GENETICS AND CYTOGENETICS (2005)
Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor
S Doumas et al.
INFECTION AND IMMUNITY (2005)
Gene therapy with secretory leukoprotease inhibitor promoter-controlled replication-competent adenovirus for non-small cell lung cancer
M Maemondo et al.
CANCER RESEARCH (2004)
Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection
G Ma et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Secretory leucoprotease inhibitor impairs toll-like receptor 2-and 4-mediated responses in monocytic cells
CM Greene et al.
INFECTION AND IMMUNITY (2004)
GSK3-Mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity
P Viatour et al.
MOLECULAR CELL (2004)
Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells
N Devoogdt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Profile of gene expression induced by the tumour promotor TPA in murine epithelial cells
J Schlingemann et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice
A Nakamura et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Mouse SWAM1 and SWAM2 are antibacterial proteins composed of a single whey acidic protein motif
K Hagiwara et al.
JOURNAL OF IMMUNOLOGY (2003)
Conversion of proepithelin to epithelins: Roles of SLPI and elastase in host defense and wound repair
J Zhu et al.
CELL (2002)
A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein
A Clauss et al.
BIOCHEMICAL JOURNAL (2002)
Secretory leukocyte protease inhibitor mediates proliferation of human endometrial epithelial cells by positive and negative regulation of growth-associated genes
DY Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing
GS Ashcroft et al.
NATURE MEDICINE (2000)
Effects of secretory leucocyte protease inhibitor on the production of the anti-inflammatory cytokines, IL-10 and transforming growth factor-beta (TGF-β), by lipopolysaccharide-stimulated macrophages
C Sano et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)
Secretory leukoprotease inhibitor augments hepatocyte growth factor production in human lung fibroblasts
T Kikuchi et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2000)
Share Paper
